Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder

Innovations in Clinical Neuroscience

Robert Lasser¹  Michael E. Thase¹  Sharon Youcha¹  Scott H. Kollins¹ 

关键词: lisdexamfetamine dimesylate;    LDX;    Vyvanse;    ADHD;    comorbidities;    substance use disorder;    depression;   

DOI  :  

学科分类：精神健康和精神病学

来源: Matrix Medical Communications, LLC

【 摘 要 】

Objective: To evaluate the efficacy and safety of lisdexamfetamine dimesylate in participants with attention deficit hyperactivity disorder and a history of depression and/or substance use disorder. History of these comorbidities was recorded from medical history forms completed by the study clinicians.

【 授权许可】

Unknown